Form 4: OmniAb Director Philip Gotwals Receives Significant Equity Grants

OmniAb, Inc. Director Philip J. Gotwals was granted 20,000 Restricted Stock Units and 40,000 Stock Options, aligning his interests with shareholders.

Summary

• Philip J. Gotwals, a Director of OmniAb, Inc. (OABI), reported the acquisition of derivative securities on June 17, 2025.
• He was granted 20,000 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of OmniAb's Common Stock.
• These RSUs will vest in full on the earlier of the date of the next annual meeting of the Company's stockholders following the grant date or the first anniversary of the grant date.
• Following this transaction, Mr. Gotwals beneficially owns 60,000 Restricted Stock Units.
• Additionally, Mr. Gotwals was granted 40,000 Stock Options (right to buy) with an exercise price of $1.7 per share.
• Each Stock Option will vest and become exercisable in full on the earlier of the date of the next annual meeting of the Company's stockholders following the grant date or the first anniversary of the date of grant.
• The Stock Options have an expiration date of June 17, 2035.
• Following this transaction, Mr. Gotwals beneficially owns 40,000 Stock Options.

Sentiment

Score: 6

Explanation: The grants of equity to a director are a standard compensation practice that aligns the director's interests with shareholder value, indicating a positive commitment from management and a common method of incentivizing long-term performance.

Positives

• The granting of equity (Restricted Stock Units and Stock Options) to a director like Philip J. Gotwals aligns his financial interests directly with the long-term performance and shareholder value of OmniAb, Inc.
• This is a standard practice in corporate governance to incentivize directors to make decisions that benefit the company and its shareholders.

Future Outlook

The Restricted Stock Units and Stock Options granted to Director Philip J. Gotwals are set to vest in full on the earlier of the next annual meeting of the Company's stockholders following the grant date or the first anniversary of the grant date, indicating future equity ownership for the director.

Industry Context

The granting of equity awards to directors is a common and widely accepted practice across various industries, including biotechnology and pharmaceuticals, to attract and retain talent, and to align the interests of leadership with those of the company's shareholders.

Stakeholder Impact

• Shareholders: The equity grants to Director Philip J. Gotwals further align his interests with those of the shareholders, potentially leading to decisions that enhance long-term shareholder value.

Next Steps

• Vesting of 20,000 Restricted Stock Units and 40,000 Stock Options based on specified conditions (earlier of next annual meeting or first anniversary of grant date).

Key Dates

Keywords

OmniAb, OABI, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, RSU, Stock Options, Director Compensation, Beneficial Ownership